170 related articles for article (PubMed ID: 10223411)
1. Are Campylobacter curvus and Campylobacter upsaliensis antecedent infectious agents in Guillain-Barré and Fisher's syndromes?
Koga M; Yuki N; Takahashi M; Saito K; Hirata K
J Neurol Sci; 1999 Feb; 163(1):53-7. PubMed ID: 10223411
[TBL] [Abstract][Full Text] [Related]
2. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes.
Koga M; Yuki N; Takahashi M; Saito K; Hirata K
J Neuroimmunol; 1998 Jan; 81(1-2):138-43. PubMed ID: 9521615
[TBL] [Abstract][Full Text] [Related]
3. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
Yuki N
J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
[TBL] [Abstract][Full Text] [Related]
4. Guillain-Barré and Fisher's syndromes subsequent to Campylobacter jejuni enteritis are associated with HLA-B54 and Cw1 independent of anti-ganglioside antibodies.
Koga M; Yuki N; Kashiwase K; Tadokoro K; Juji T; Hirata K
J Neuroimmunol; 1998 Aug; 88(1-2):62-6. PubMed ID: 9688325
[TBL] [Abstract][Full Text] [Related]
5. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies.
Kimoto K; Koga M; Odaka M; Hirata K; Takahashi M; Li J; Gilbert M; Yuki N
Neurology; 2006 Nov; 67(10):1837-43. PubMed ID: 17130419
[TBL] [Abstract][Full Text] [Related]
6. [Anti-GQ1b IgG-negative case of overlapping Fisher's and Gullain-Barré syndromes after Campylobacter jejuni (PEN 19) enteritis].
Hayashi Y; Koga M; Takahashi M; Uchida A; Yuki N
Rinsho Shinkeigaku; 2001 Nov; 41(11):801-4. PubMed ID: 12080613
[TBL] [Abstract][Full Text] [Related]
7. Guillain-Barré syndrome and Fisher's syndrome following Campylobacter jejuni infection.
Yuki N; Miyatake T
Ann N Y Acad Sci; 1998 Jun; 845():330-40. PubMed ID: 9668366
[TBL] [Abstract][Full Text] [Related]
8. Is Campylobacter lipopolysaccharide bearing a GD3 epitope essential for the pathogenesis of Guillain-Barré syndrome?
Yuki N; Koga M; Hirata K
Acta Neurol Scand; 2000 Aug; 102(2):132-4. PubMed ID: 10949532
[TBL] [Abstract][Full Text] [Related]
9. [Serological study of Campylobacter jejuni infections in patients with Guillain-Barré syndrome].
Takahashi M; Saitoh K; Ohta K; Kudoh Y
Kansenshogaku Zasshi; 1994 Apr; 68(4):467-73. PubMed ID: 8027593
[TBL] [Abstract][Full Text] [Related]
10. Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barré syndrome.
Schmidt-Ott R; Schmidt H; Feldmann S; Brass F; Krone B; Gross U
Clin Vaccine Immunol; 2006 Jul; 13(7):779-83. PubMed ID: 16829615
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barré and Fisher syndromes in Japan.
Takahashi M; Koga M; Yokoyama K; Yuki N
J Clin Microbiol; 2005 Jan; 43(1):335-9. PubMed ID: 15634991
[TBL] [Abstract][Full Text] [Related]
12. Anti-ganglioside antibodies in patients with Guillain-Barré syndrome and Campylobacter jejuni infection.
Rees JH; Gregson NA; Hughes RA
J Infect Dis; 1995 Aug; 172(2):605-6. PubMed ID: 7622918
[No Abstract] [Full Text] [Related]
13. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.
Oomes PG; Jacobs BC; Hazenberg MP; Bänffer JR; van der Meché FG
Ann Neurol; 1995 Aug; 38(2):170-5. PubMed ID: 7654064
[TBL] [Abstract][Full Text] [Related]
14. Guillain-Barre syndrome and Campylobacter infection.
Prasad KN; Pradhan S; Nag VL
Southeast Asian J Trop Med Public Health; 2001 Sep; 32(3):527-30. PubMed ID: 11944711
[TBL] [Abstract][Full Text] [Related]
15. Association between Campylobacter infection and Guillain-Barré syndrome.
Allos BM
J Infect Dis; 1997 Dec; 176 Suppl 2():S125-8. PubMed ID: 9396695
[TBL] [Abstract][Full Text] [Related]
16. Association study between an outbreak of Guillain-Barre syndrome in Jilin, China, and preceding Campylobacter jejuni infection.
Zhang M; Li Q; He L; Meng F; Gu Y; Zheng M; Gong Y; Wang P; Ruan F; Zhou L; Wu J; Chen L; Fitzgerald C; Zhang J
Foodborne Pathog Dis; 2010 Aug; 7(8):913-9. PubMed ID: 20455754
[TBL] [Abstract][Full Text] [Related]
17. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
Jacobs BC; van Doorn PA; Schmitz PI; Tio-Gillen AP; Herbrink P; Visser LH; Hooijkass H; van der Meché FG
Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.
Yuki N
Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987
[TBL] [Abstract][Full Text] [Related]
19. [No association between IgG anti-GTla antibody and bulbar palsy in Guillain-Barré and Fisher's syndromes].
Koga M; Yuki N; Hirata K
Rinsho Shinkeigaku; 1997 Nov; 37(11):1024-6. PubMed ID: 9503976
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
Prendergast MM; Moran AP
J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
